News

On its five-year anniversary, Medexprim is presenting R-WiDE 2025 (From Real-World Imaging Data to Evidence), its five-year strategic plan. This growth plan aims to accelerate clinical research by: Unleashing imaging and clinical data in clinical …
Romain Cazavan, CEO of Medexprim, spoke with Aïssa Khelifa for DSIH, the French professional magazine devoted to Health IT. The interview was published on December 1, 2020 (read the original French version here). AKH: Hello Romain, …
Medexprim is proud to be the only French startup, as well as the only European Real-World Data and Real-World Evidence company, to have been selected by Euroquity for the Access2EIC – Seal of Excellence e-Pitch …

Join us!

Medexprim is hiring a HIS Interoperability Specialist – Data Manager. If you wish to join the Real-World Imaging Evidence ecosystem, contribute to the growth of an innovative company and evolve in a rich multidisciplinary environment, …
Medexprim is very proud to start its new collaboration in the H2020 EU CHAIMELEON project. CHAIMELEON aims to set up a structured repository for health imaging data to be openly reused in AI experimentation for …
Medexprim Suite™ is now bigger and better than ever before, with the simultaneous release of Radiomics Enabler® Version 1.4 and 1.5. Under the hood, these two versions have exactly the same functionality. Aditionally, v.1.5 updates Medexprim …
This summer, Medexprim received the European Commission’s Seal of Excellence for MIDAC (Medical Imaging Data Against Coronavirus), our project submitted to the EIC Accelerator COVID call. MIDAC’s goal was to constitute a centralized, collaborative and …

Join us !

EDIT – This position has been filled 🙂 Medexprim is hiring it Responsable Marketing & Partnerships Manager. If you wish to contribute to the progress of medicine and to evolve in a rich multidisciplinary environment, …
In this webinar Medexprim and Graticule convened a panel of experts that bridge across geographies and backgrounds to discuss solutions for sharing advanced Real World Data for COVID-19 research. The panel shares their expertise on …
Medexprim is very pleased and proud to announce a joint Medexprim /Graticule on Tuesday 28 April @ 6PM CET, 12PM EST “Bridging global COVID-19 RWE initiatives between care providers and pharma”. The goal is to …
Karine Seymour, founder of Medexprim, hands over the Presidency of the company to Romain Cazavan. She continues to manage the Operations Department and the product management. Medexprim, a hyper-growth company specialized in “big data” in …

Join us!

EDIT – This position has been filled 🙂 Medexprim is hiring its Delivery Manager and a Software Developer. If you wish to contribute to the progress of medicine and to evolve in a rich multidisciplinary …
Romain Cazavan from Medexprim explains the nature of our partnership with Sophia Genetics and how we contribute to providing cleaned data to advance discoveries to fight cancer.
Boston, Mass – US-based Graticule and France based Medexprim announced a partnership today to provide a federated global network to power complex RWE (Real World Evidence) studies. The two companies have established complementary infrastructure and …
Medexprim has just turned 4 and is running many projects! Do you have talents in Python SW development, system engineering, data science or project management? Interested in topics like personalized medicine and medical research?  Interested …
In order to support our strong growth, our international deployment, and our commitments within the very ambitious and innovative European project (see https://www.primageproject.eu), we are looking for a Python Software Engineer. The position is based in Toulouse, …
Overland Park, KS – US-based Softek Illuminate and the entrepreneurial French firm Medexprim announced today they will be combining, distributing and supporting each other’s product offerings as a unified solution for hospital researchers interested in …
Sword Group and Medexprim are partnering in view to offer cancer centers and large hospitals a unified solution to facilitate translational research, combining clinical and imaging data.